- Home
- LTC vs ELVN Comparison
LTC vs ELVN Comparison
Compare LTC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTC | ELVN |
|---|---|---|
| Founded | 1992 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LTC | ELVN |
|---|---|---|
| Price | $37.16 | $36.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $40.00 | ★ $43.40 |
| AVG Volume (30 Days) | 424.2K | ★ 794.6K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.96% | N/A |
| EPS Growth | ★ 23.53 | 3.17 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $262,854,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $76.27 | ★ N/A |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $33.64 | $14.79 |
| 52 Week High | $40.80 | $48.53 |
Technical Indicators
Market Signals| Indicator | LTC | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 44.73 |
| Support Level | $35.62 | $19.19 |
| Resistance Level | $39.65 | $40.62 |
| Average True Range (ATR) | 0.84 | 1.98 |
| MACD | -0.06 | -0.42 |
| Stochastic Oscillator | 62.51 | 39.12 |
Price Performance
Historical ComparisonAbout LTC LTC Properties Inc.
LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.